Skip to main content
. Author manuscript; available in PMC: 2023 Sep 19.
Published in final edited form as: J Med Chem. 2021 Sep 16;64(19):14702–14714. doi: 10.1021/acs.jmedchem.1c01214

Table 1.

Structures and activity of 3-chloropyridinyl ester-derived SARS-CoV-2 3CLpro inhibitors.

Entry Entry Compound Structure SARS CoV-2 3CLpro IC50 (μM) SARS-CoV-2 EC50 (μM)a

1 graphic file with name nihms-1922472-t0011.jpg 0.25 2.8
2 graphic file with name nihms-1922472-t0012.jpg 0.32 15
3 graphic file with name nihms-1922472-t0013.jpg 0.31 43.7
4 graphic file with name nihms-1922472-t0014.jpg 0.12 69.8
5 graphic file with name nihms-1922472-t0015.jpg 0.90 8.1
6 graphic file with name nihms-1922472-t0016.jpg 0.073 15
7 graphic file with name nihms-1922472-t0017.jpg 0.38 11.5
8 graphic file with name nihms-1922472-t0018.jpg 0.47 56.7
9 graphic file with name nihms-1922472-t0019.jpg 10.3 >100
10 graphic file with name nihms-1922472-t0020.jpg 0.59 3.1
11 graphic file with name nihms-1922472-t0021.jpg 0.87 14
12 graphic file with name nihms-1922472-t0022.jpg 0.34 >100
13 graphic file with name nihms-1922472-t0023.jpg 0.49 57.1
14 graphic file with name nihms-1922472-t0024.jpg 1.19 >100
15 graphic file with name nihms-1922472-t0025.jpg 0.42 >100
a

Compounds 3 and 4 exhibited antiviral EC50 values 3.4 μM and 3.2 μM, respectively.